Global Tissue Heart Valves Market 2016-2020
|発行||TechNavio (Infiniti Research Ltd.)||商品コード||353214|
|出版日||ページ情報||英文 41 Pages
Heart valves are prosthetic cardiovascular medical devices that are used to replace a defective heart valve. These valves can be biological (tissue) or mechanical. Manufacturers develop tissue heart valves from various sources such as bovine, porcine, and human tissues. Devices developed using human tissues are known as allografts or homografts. The implantation of these devices does not require the lifelong use of blood-thinner medications compared to mechanical tissue heart valves. They also ensure unidirectional flow of the blood across heart chambers. The medical facilities worldwide perform about 300,000 heart valve replacement procedures each year.
Technavio's analysts forecast the global tissue heart valves market to grow at a CAGR of 3.81% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global tissue heart valves market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of tissue heart valve implants.
The market is divided into the following segments based on geography:
Technavio's report, Global Tissue Heart Valves Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.